Patents by Inventor Xing Cheng

Xing Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8163530
    Abstract: The complete polynucleotide sequence of the human respiratory syncytial virus subgroup B strain 9320 genome is provided. Proteins encoded by this polynucleotide sequence are also provided. Isolated or recombinant RSV (e.g., attenuated recombinant RSV), nucleic acids, and polypeptides, e.g., comprising mutations in the attachment protein G, are also provided, as are immunogenic compositions comprising such isolated or recombinant RSV, nucleic acids, and polypeptides. Related methods are also described.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: April 24, 2012
    Assignee: MedImmune, LLC
    Inventors: Xing Cheng, Hyun Jung Park, Hong Jin
  • Patent number: 8119661
    Abstract: Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein R2, R3, X, m and n are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Grant
    Filed: September 8, 2008
    Date of Patent: February 21, 2012
    Assignee: AstraZeneca AB
    Inventors: Yun-Xing Cheng, Xuehong Luo, Vijayaratnam Santhakumar, Miroslaw Jerzy Tomaszewski
  • Patent number: 7956069
    Abstract: Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein A1, A2, G1, G2 G3, R1, R2, X, Y, Z, m, n and p are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Grant
    Filed: June 8, 2007
    Date of Patent: June 7, 2011
    Assignee: AstraZeneca AB
    Inventors: Yun-Xing Cheng, Mehrnaz Pourashraf, Miroslaw Tomaszewski
  • Publication number: 20110040393
    Abstract: A method and apparatus for intelligently controlling continuous process variables. A Dream Controller comprises an intelligent Engine mechanism and a number of Model-Free Adaptive (MFA) controllers, each of which is suitable to control a process with specific behaviors. The Intelligent Engine can automatically select the appropriate MFA controller and its parameters so that the Dream Controller can be easily used by people with limited control experience and those who do not have the time to commission, tune, and maintain automatic controllers.
    Type: Application
    Filed: August 10, 2010
    Publication date: February 17, 2011
    Applicant: GENERAL CYBERNATION GROUP, INC.
    Inventors: George Shu-Xing CHENG, Steven L. Mulkey, Qiang Wang, Andrew J. Chow
  • Publication number: 20110012430
    Abstract: A method and apparatus is disclosed for intelligently inverting DC power from DC sources such as photovoltaic (PV) solar modules to single-phase or three-phase AC power to feed the power grid for electricity generation. A number of smart single-input, dual-input, triple-input, quad-input, and multiple-input power inverters in a mixed variety can easily connect to single, dual, triple, quad, and multiple DC power sources, invert the DC power to AC power, and daisy chain together to generate a total power, which is equal to the summation of the AC power supplied by each smart and scalable power inverter of this invention.
    Type: Application
    Filed: July 15, 2010
    Publication date: January 20, 2011
    Applicant: GENERAL CYBERNATION GROUP, INC.
    Inventors: George Shu-Xing CHENG, Steven L. Mulkey
  • Publication number: 20100330118
    Abstract: Polypeptides, polynucleotides, reassortant viruses, immunogenic compositions and vaccines comprising influenza hemagglutinin and neuraminidase variants and method using thereof are provided.
    Type: Application
    Filed: February 3, 2010
    Publication date: December 30, 2010
    Applicants: MEDIMMUNE, LLC, The Government of the United States of America, National Institutes of Health
    Inventors: Hong JIN, Xing CHENG, Kanta SUBBARAO
  • Publication number: 20100173941
    Abstract: Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4, R5, R6, R7, m and n are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: June 8, 2007
    Publication date: July 8, 2010
    Applicant: AstraZeneca AB
    Inventors: Yun-Xing Cheng, Miroslaw Tomaszewski
  • Publication number: 20100173935
    Abstract: Compounds of Formula IA, or pharmaceutically acceptable salts thereof: IA wherein G1, G2, G3, G4, R1, R2, X, Y, Z and n are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: June 8, 2007
    Publication date: July 8, 2010
    Applicant: AstraZeneca AB
    Inventors: Yun-Xing Cheng, Shujuan Jin, Mehrnaz Pourashraf, Miroslaw Tomaszewski
  • Publication number: 20100113502
    Abstract: Compounds of formulae I, or pharmaceutically acceptable salts thereof: wherein R1, R2 and R3 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: March 17, 2006
    Publication date: May 6, 2010
    Applicant: ASTRAZENECA AB
    Inventors: Yun-Xing Cheng, Miroslaw Tomaszewski
  • Publication number: 20100073296
    Abstract: A computer input apparatus includes a keyboard and a mouse. The keyboard includes a housing, a number of input keys, and a telephone module for responding to a call or initiating a call according to a user's input. The input keys include standard keyboard keys and standard telephone keys. The mouse includes a main body, a number of buttons mounted on the main body, and a motion detecting unit for detecting motion of the mouse. The main body includes a mouse speaker configured for converting electrical signals into sound and a mouse microphone configured for converting sound into electrical signals. The buttons include a number of standard mouse buttons and an enable telephone button configured for enabling a telephone function of the mouse to answer a call.
    Type: Application
    Filed: July 21, 2009
    Publication date: March 25, 2010
    Applicants: HONG FU JIN PRECISION INDUSTRY (ShenZhen) CO., LTD, HON HAI PRECISION INDUSTRY CO., LTD.
    Inventor: XING-CHENG LIU
  • Patent number: 7648767
    Abstract: A material composition, which is used as a liquid resist, includes a first component comprising a monomer portion and at least one cationically polymerizable functional group, and a crosslinker reactive with the first component and comprising at least three cationically polymerizable functional groups. The material composition also includes a cationic photoinitiator. Upon exposure to UV light, the material composition crosslinks via cure to form a cured resist film that is the reaction product of the first component, the crosslinker, and the cationic photoinitiator. An article includes a substrate layer and a resist layer formed on the substrate layer from the material composition.
    Type: Grant
    Filed: June 1, 2005
    Date of Patent: January 19, 2010
    Assignee: Dow Corning Corporation
    Inventors: Peng Fei Fu, Lingjie Jay Guo, Xing Cheng
  • Publication number: 20090285853
    Abstract: The complete polynucleotide sequence of the human respiratory syncytial virus subgroup B strain 9320 genome is provided. Proteins encoded by this polynucleotide sequence are also provided. Isolated or recombinant RSV (e.g., attenuated recombinant RSV), nucleic acids, and polypeptides, e.g., comprising mutations in the attachment protein G, are also provided, as are immunogenic compositions comprising such isolated or recombinant RSV, nucleic acids, and polypeptides. Related methods are also described.
    Type: Application
    Filed: July 23, 2009
    Publication date: November 19, 2009
    Applicant: MEDIMMUNE, LLC
    Inventors: Xing Cheng, Hyun Jung Park, Hong Jin
  • Publication number: 20090275574
    Abstract: Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4, m, n, q, s, t, X, and Y are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: April 30, 2009
    Publication date: November 5, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Yun-Xing Cheng, Vijayaratnam Santhakumar, Miroslaw Jerzy Tomaszewski
  • Publication number: 20090221567
    Abstract: Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein Y, X, A, R1, R2, m, p, and q are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: February 25, 2009
    Publication date: September 3, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Yun-Xing Cheng, Xuehong Luo, Mehrnaz Pourashraf, Vijayaratnam Santhakumar, Miroslaw Jerzy Tomaszewski
  • Patent number: 7572904
    Abstract: The complete polynucleotide sequence of the human respiratory syncytial virus subgroup B strain 9320 genome is provided. Proteins encoded by this polynucleotide sequence are also provided. Isolated or recombinant RSV (e.g., attenuated recombinant RSV), nucleic acids, and polypeptides, e.g., comprising mutations in the attachment protein G, are also provided, as are immunogenic compositions comprising such isolated or recombinant RSV, nucleic acids, and polypeptides. Related methods are also described.
    Type: Grant
    Filed: March 26, 2004
    Date of Patent: August 11, 2009
    Assignee: MedImmune, LLC
    Inventors: Xing Cheng, Hyun Jung Park, Hong Jin
  • Publication number: 20090076078
    Abstract: Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein R2, R3, X, m and n are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: September 8, 2008
    Publication date: March 19, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Yun-Xing Cheng, Xuehong Luo, Vijayaratnam Santhakumar, Miroslaw Jerzy Tomaszewski
  • Publication number: 20090035469
    Abstract: A dispersible nanocomposite comprising nanotubes associated with nanoplatelets. A method for creating an exfoliated nanotubes solution, aligning nanotubes and depositing them on a substrate or in matrix. In one embodiment, the method includes a nanocomposite of at least one nanotube electrostatically associated with at least one nanoplatelet. The nanoplatelets may be removed from the suspension by altering the ionic strength to create an exfoliated nanotube solution. The exfoliated nanotube solution for injection into microchannel templates and aligned deposition.
    Type: Application
    Filed: April 30, 2008
    Publication date: February 5, 2009
    Applicant: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Hung-Jue Sue, Xing Cheng, Dazhi Sun, Huifeng Li, Chien-Chia Chu
  • Patent number: 7415446
    Abstract: An apparatus and method is disclosed for solving optimization problems without the need to build mathematical models or rules. The inventive method combines the structure of a single-loop feedback control system and optimization search engine mechanisms. Running in real-time, a Model-Free Adaptive (MFA) optimizer can automatically search for the optimal operating point for a dynamic system when a parabolic relationship exists between the input and output. The MFA optimizer comprises a user-selected Min/Max setter to define the searching objective, a process acting-mode search engine to determine if the process is running in direct-acting or reverse-acting mode, a maximum search engine and a minimum search engine to find the maximum or minimum. This apparatus and method is useful in fuel-and-air ratio optimization for combustion processes, yield optimization for chemical or biological reactors, and operating efficiency optimization for coal or ore ball mills.
    Type: Grant
    Filed: October 19, 2004
    Date of Patent: August 19, 2008
    Assignee: General Cybernation Group, Inc.
    Inventors: George Shu-Xing Cheng, Steven L. Mulkey
  • Patent number: 7374864
    Abstract: A method of fabricating a device including imprinting a mold having a protrusion against a substrate having a resist layer such that the protrusion engages the resist layer. The mold further has a mask member positioned generally adjacent the resist layer. Radiation energy is then transmitted through the mold and into the resist layer; however, the mask member substantially prevents transmission of the radiation energy therethrough, thereby defining an unexposed area in the resist layer. Once the mold is removed from the substrate, which consequently forms a first feature from nanoimprinting, the unexposed area of resist layer is removed through dissolving in a developer solution.
    Type: Grant
    Filed: February 13, 2004
    Date of Patent: May 20, 2008
    Assignee: The Regents of the University of Michigan
    Inventors: Lingjie J. Guo, Xing Cheng
  • Publication number: 20070287695
    Abstract: Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein A1, A2, G1, G2 G3, R1, R2, X, Y, Z, m, n and p are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: June 8, 2007
    Publication date: December 13, 2007
    Applicant: ASTRAZENECA AB
    Inventors: Yun-Xing Cheng, Mehrnaz Pourashraf, Miroslaw Tomaszewski